Log In
Print
BCIQ
Print
Print this Print this
 

Oxigon (OX1, SHP622)

Also known as: VP20629

  Manage Alerts
Collapse Summary General Information
Company Intellect Neurosciences Inc.
DescriptionAntioxidant and anti-amyloid compound
Molecular Target Beta amyloid
Mechanism of ActionAntioxidant; Disrupts amyloid plaques
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAtaxia
Indication DetailsTreat Friedreich's ataxia (FRDA)
Regulatory Designation
Partner Shire plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$126.5M

$6.5M

$120.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today